Pr. Peter van Endert
Peter van Endert, MD, PhD is a professor of immunology at University Paris Descartes head of the department of immunology, microbiology and hematology at Institut Necker Enfants Malades (INEM; a public research center with 15 teams and about 250 workers) and head of the team “Antigen presentation by MHC molecules: mechanisms and impact of Toll-like receptors” at INEM. His primary research focuses on different aspects of antigen presentation cell biology but he also studies cellular autoimmunity in type 1-diabetes. He has made major contributions to understanding the function and specificity of the TAP peptide transporters and discovered the role the ERAP2 and IRAP aminopeptidases in endogenous and exogenous antigen presentation by MHC class I molecules. He has published 124 PubMed-cited publications. His h-index is 41, with an average 45 citations per article. He is an associate editor of the Journal of Immunology and of Frontiers in Antigen Presenting Cell Biology. He has obtained 26 third party grants since establishing his group in Paris, among them 21 obtained as principal investigator. These grants included 15 international grants including 7 by the Juvenile Diabetes Research Foundation (New York) and 4 by the European Commission; Dr. van Endert coordinated one of the European network grants. Since establishing his laboratory in Paris in 1993, he has trained 13 students in Master 2 programs and supervised 18 PhD students as well as 14 postdoctoral fellows. The latter include two scientists now directing research units or teams in French public research institutes, and one associate professor at Albert Einstein College of Medicine. Dr. van Endert is also in charge of teaching immunology to medical students at University Paris Descartes and organizes a tutoring program accompanying PhD students at the Necker Enfants Malades Institute.